PROVIDENCE, R.I.--(BUSINESS WIRE)--Tivorsan Pharmaceuticals, Inc. (Tivorsan) today announced that it met its fourth (4th) set of critical milestones under its existing grants from Parent Project Muscular Dystrophy (PPMD) and Muscular Dystrophy Association (MDA). The achievement of these milestones triggers additional payments to Tivorsan pursuant to the Company’s $565,000 grant from PPMD and $1,000,000 grant from MDA.
Help employers find you! Check out all the jobs and post your resume.
